Page 9 - Trials Network News Today

The federal court ruling against requiring health care insurers to cover PrEP could result in more than 2,000 new and preventable HIV infections among at-risk populations within 12 months of the ruling.

An interim analysis determined that the regimen was not effective in preventing infections, compared with placebo.

Top South African HIV clinicians are setting their sights on different approaches to finding an HIV vaccine after the ‘disappointing’ news that the Mosaico trial was stopped early because the vaccine did not show any efficacy. The search for an HIV jab now seems set to shift from vaccines that...

Hopes for the Johnson & Johnson (J&J) Mosaico vaccine were dashed when the manufacturer announced that the vaccine lacked efficacy in preventing HIV infection.

The 4-decades long effort to create an AIDS vaccine suffered a blow with news that a vaccine in a late stage trial was discontinued because results showed it to be ineffective. What are the obstacles?

The 4-decades long effort to create an AIDS vaccine suffered a blow with news that a vaccine in a late stage trial was discontinued because results showed it to be ineffective. What are the obstacles?

The 4-decades long effort to create an AIDS vaccine suffered a blow with news that a vaccine in a late stage trial was discontinued because results showed it to be ineffective. What are the obstacles?

The 4-decades long effort to create an AIDS vaccine suffered a blow with news that a vaccine in a late stage trial was discontinued because results showed it to be ineffective. What are the obstacles?

The 4-decades long effort to create an AIDS vaccine suffered a blow with news that a vaccine in a late stage trial was discontinued because results showed it to be ineffective. What are the obstacles?

The 4-decades long effort to create an AIDS vaccine suffered a blow with news that a vaccine in a late stage trial was discontinued because results showed it to be ineffective. What are the obstacles?